iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Up 134.2% in June

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a large increase in short interest in the month of June. As of June 15th, there was short interest totaling 12,988 shares, an increase of 134.2% from the May 31st total of 5,546 shares. Approximately 8.7% of the shares of the stock are short sold. Based on an average trading volume of 2,385 shares, the short-interest ratio is presently 5.4 days.

iShares Neuroscience and Healthcare ETF Price Performance

IBRN traded down $0.52 during midday trading on Wednesday, reaching $38.31. 2,359 shares of the company’s stock were exchanged, compared to its average volume of 2,023. iShares Neuroscience and Healthcare ETF has a 1-year low of $21.96 and a 1-year high of $39.39. The stock has a market capitalization of $5.75 million, a PE ratio of 15.61 and a beta of 0.77. The business’s 50-day moving average price is $35.33 and its 200 day moving average price is $33.39.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.